SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001654954-20-007499
Filing Date
2020-07-09
Accepted
2020-07-09 16:16:18
Documents
4
Period of Report
2020-07-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT gtbp_8k.htm 8-K 32067
2 FORM OF SECURED CONVERTIBLE NOTE gtbp_ex41.htm EX-4.1 178059
3 SECURITIES PURCHASE AGREEMENT gtbp_ex101.htm EX-10.1 321771
4 REGISTRATION RIGHTS AGREEMENT gtbp_ex103.htm EX-10.3 162953
  Complete submission text file 0001654954-20-007499.txt   696358
Mailing Address 310 N. WESTLAKE BLVD. SUITE 206 WESTLAKE VILLAGE CA 91362
Business Address 310 N. WESTLAKE BLVD. SUITE 206 WESTLAKE VILLAGE CA 91362 (800) 304-9888
GT Biopharma, Inc. (Filer) CIK: 0000109657 (see all company filings)

IRS No.: 941620407 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-08092 | Film No.: 201020637
SIC: 2834 Pharmaceutical Preparations